Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
08.01.26
/
50%
€160.80
Target price
08.01.27
-
Performance (%)
-7.99%
Price
22.01.26
€147.95
Summary
This prediction is currently active. With a performance of -7.99%, the BUY prediction by The_Goldman_Sachs_Gr is trending in the wrong direction. This prediction currently runs until 08.01.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | 1.824% |
| iShares Core DAX® | -1.673% |
| iShares Nasdaq 100 | -1.346% |
| iShares Nikkei 225® | -1.529% |
| iShares S&P 500 | -1.702% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for BIIB provided by MarketBeat